With big pharma more hungry than ever for new R&D collaborations and M&A, dealmaking has hit a fever pitch as we enter 2020. The JPMorgan conference offers a perfect opportunity for getting several top dealmakers from both sides of the table to discuss how to work the best deal for your company, from upfronts to milestones and equity. And you can get an exclusive first look at our exclusive special report on 2019’s top deals from DealForma’s Chris Dokomajilar.
2020 marks a critical crossroad in the debate over drug prices and what lawmakers intend to do about it. Import from Canada? Leverage European pricing? Value pricing? What’s real and what’s another red herring with no chance of success? Our panel of pharma execs and pricing critics will tackle the biggest of issues facing all of biopharma and offering ideas of which way we’ll turn in the months ahead. We are shaping the future now.